Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes*

Shannon H Fourtner1, Stuart A Weinzimer, Lorraine E Levitt Katz

  • 1Department of Pediatrics, Division of Endocrinology/Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. fourtner@email.chop.edu

Pediatric Diabetes
|August 20, 2005
PubMed

Insights

Hyperglycemic hyperosmolar non-ketotic (HHNK) syndrome, though rare in children, occurred in 3.7% of new type 2 diabetes cases. While most survivors had no lasting effects, the syndrome presented a significant mortality risk.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Mellitus

Background:

  • Hyperglycemic hyperosmolar non-ketotic (HHNK) syndrome is considered rare in children.
  • Increasing prevalence of childhood obesity and type 2 diabetes may lead to more HHNK syndrome cases.
  • Existing literature primarily consists of case reports, lacking updated information on typical clinical course and outcomes.

Purpose of the Study:

  • To provide updated information on the clinical course and sequelae of HHNK syndrome in pediatric patients.
  • To assess the frequency of HHNK syndrome in children diagnosed with type 2 diabetes.
  • To highlight the association between HHNK syndrome and new-onset type 2 diabetes in children.

Main Methods:

  • Retrospective chart review of patients diagnosed with type 2 diabetes at Children's Hospital of Philadelphia over 5 years.
  • Screening for laboratory evidence of HHNK syndrome using standard diagnostic criteria (blood glucose >600 mg/dL, serum osmolality >330 mOsm/L, mild acidosis).
  • Analysis of clinical presentation, demographic data, and patient outcomes.

Main Results:

  • Seven out of 190 patients (3.7%) with type 2 diabetes met the criteria for HHNK syndrome.
  • All seven patients were African-American, with a mean age of 13.3 years, and HHNK syndrome was their initial presentation of diabetes.
  • The case fatality rate was 14.3% (one death), with survivors experiencing an average hospital stay of 10 days and no neurodevelopmental sequelae.

Conclusions:

  • HHNK syndrome occurs in a notable percentage of pediatric type 2 diabetes cases.
  • Increased awareness of type 2 diabetes in children is crucial for preventing HHNK syndrome.
  • Early recognition and management can mitigate the significant morbidity and mortality associated with HHNK syndrome in pediatric patients.
Abstract

Related Concept Videos

Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...